In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Stellar Biotechnologies, Inc.. Trade Record

NASDAQ:SBOT Stellar Biotechnologies, Inc. stock gains 226.39% Exit May 11, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart SBOT May 3, 2018, priceSeries
About Stellar Biotechnologies, Inc.

Stellar Biotechnologies, Inc., a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein primarily in Europe, the United States, and Asia. KLH is an immune-stimulating protein used for generation of antibody and cell-mediated immune responses against disease indications, such as cancer, immune disorders, Alzheimer's, and inflammatory diseases, as well as used for therapeutic vaccine conjugation in immunotherapies. The company also offers in vitro diagnostic kits for preclinical use. It provides its products under the Stellar KLH brand name. The company serves multinational biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers. Stellar Biotechnologies, Inc. is based in Port Hueneme, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
99.60
Entry Date
May 3, 2018
Entry Price
0.72
Sell Date
May 11, 2018
Sell Price
2.35
Net Gain
226.39%
Hold Time
6 Trading Days